FDA MDICC

Medical Device Interoperability Coordination Council (MDICC) Clinical Needs and Clinical Landscape Team

We participated in a 2012 FDA initiative to form a Medical Device Interoperability Coordination Council (MDICC) to synchronize the multitude of efforts being pursued by different groups around device interoperability. Dr. Julian Goldman led the MDICC group on Clinical Landscape & Clinical Needs, contributing our NIH Quantum scenarios as well as others elicited by our program.The Clinical Needs & Clinical Landscape team, under Dr. Goldman’s leadership, compiled examples that demonstrate clinical benefits that could be realized from interoperable medical devices. Identifying currently available capabilities as well as future needs (or gaps). Given the nascent state of medical device interoperability, articulation of future (desired) states is especially important to ensure that proposed technical solutions and standards will yield useful clinical capabilities. The future-state clinical scenarios will include interoperability among medical devices, among components of integrated medical device systems, among medical devices and EHRs, among medical devices and hospital IT / CIS systems, and among (personal) medical devices and telehealth data hubs.The objectives statement and more information about MDICC CNCL team can be found here.

Note: The the Massachusetts General Hospital MD PnP Program has a Research Collaboration Agreement (RCA) with the FDA/CDRH.